| 标题 |
LBA65 Neoadjuvant durvalumab (D) + chemotherapy (CT) followed by either surgery (Sx) and adjuvant D or CRT and consolidation D in patients (pts) with resectable or borderline resectable stage IIB–IIIB NSCLC: Interim analysis (IA) of the phase II MDT-BRIDGE study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:M. Reck; N. Girard; E. Nadal; C.M. Gay; A.R. Filippi; et al 出版日期:2025-11-20 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)